Skip to main content

Advertisement

Log in

PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

The histology slides and the reconstructed PET images are available upon request.

References

  1. Zhou Y, et al. [(68) Ga]Ga-DOTA-FAPI-04 PET/CT imaging of cirrhosis with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2023;50(5):1536–7. https://doi.org/10.1007/s00259-022-06077-0.

    Article  PubMed  Google Scholar 

  2. Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol. 2019;11(1):1–18. https://doi.org/10.4254/wjh.v11.i1.1.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Yen YH, Cheng YF, Wang JH, Lin CC, Wang CC. Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: when East meets West. PloS One. 2021;16(1):e0244939. https://doi.org/10.1371/journal.pone.0244939.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Gerin JL, Cote PJ, Korba BE, Tennant BC. Hepadnavirus-induced liver cancer in woodchucks. Cancer Detect Prev. 1989;14(2): 227–9. Available: http://www.ncbi.nlm.nih.gov/pubmed/2695243.

  5. Aravalli RN, Steer CJ. “Animal models of liver cancer,” in Hepatocellular carcinoma: cellular and molecular mechanisms and novel therapeutic strategies. Cham: Springer International Publishing; 2014. p. 47–50.

    Google Scholar 

  6. Sergeeva O, et al. PET imaging of hepatocellular carcinoma using ZD2-((68)Ga-NOTA). J Hepatocell Carcinoma. 2023;10:291–301. https://doi.org/10.2147/JHC.S390939.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Attieh Y, et al. Cancer-associated fibroblasts lead tumor invasion through integrin-beta3-dependent fibronectin assembly. J Cell Biol. 2017;216(11):3509–20. https://doi.org/10.1083/jcb.201702033.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Erdogan B, et al. Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin. J Cell Biol. 2017;216(11):3799–816. https://doi.org/10.1083/jcb.201704053.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Pang Y, Wang P, Xu W, Zhao L, Chen H. Identification of isolated hepatic sarcoidosis with [(18)F]FDG and [(68) Ga]Ga-FAPI PET/CT. Eur J Nucl Med Mol Imaging. 2023. https://doi.org/10.1007/s00259-023-06236-x.

  10. Ghoneim S, Williams SD. Hepatic sarcoidosis: an uncommon cause of cirrhosis. Cureus. 2019;11(12):e6316. https://doi.org/10.7759/cureus.6316.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kratochwil C, et al. (68)Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60(6):801–5. https://doi.org/10.2967/jnumed.119.227967.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Olga Sergeeva and Wei Cao for PET imaging along with the staff of Nuclear Medicine at University Hospitals Cleveland Medical Center, ARC staff of Case Western Reserve University for animal handling, and Maxim Sergeev for providing radiopharmaceuticals for this study.

Funding

This work is supported in part by NIH R01 grants CA204373, CA235152, and CA211762 and DoD grant W81XWH-22–1-0784.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhenghong Lee.

Ethics declarations

Ethics approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Conflict of interest

Zhenghong Lee declares that he has no conflict of interest. Zheng-Rong Lu declares that he has no conflict of interest. Sandra Sexton declares that she has no conflict of interest. Wei Xin declares that he has no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, Z., Lu, ZR., Sexton, S. et al. PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 50, 3190–3191 (2023). https://doi.org/10.1007/s00259-023-06324-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-023-06324-y

Navigation